Ministry of Health and Population · Arab Republic of Egypt
Ministry of Health and Population100 Million Healthy Lives initiative
العربيةEnglishFrançais
InitiativesAll initiativesElderly Health Care Initiative"Our Children's Eyes, Our Future" InitiativeWomen's Health Support InitiativePremarital ScreeningCare for Children with Diabetes InitiativeMaternal and Fetal Health CareEarly Detection and Treatment of Cancer InitiativeInitiative for Early Detection and Treatment of Hearing Loss in NewbornsInitiative for Treating Children with Spinal Muscular AtrophyScreening and Treatment of Malnutrition among SchoolchildrenScreening and Treatment of Chronic Diseases and Early Detection of Kidney DiseaseEarly Detection of Genetic Diseases in NewbornsMental Health Support Initiative ("Your Health Is Happiness")Initiative for Mental Health Support and Early Intervention for Autism Spectrum DisordersThe Golden 1,000 Days Initiative for the Development of the Egyptian Family100 Days of Health
Health unitsAwarenessMedia centrePress releasesDocumentsFAQContact us
Press releaseEarly Detection of Genetic Diseases in Newborns

Ministry of Health: More than 735,000 Newborns Screened under the "100 Million Healthy Lives" Initiative for the Early Detection of Genetic Diseases.

5 May 2026Ministry of Health and Population
Ministry of Health: More than 735,000 Newborns Screened under the "100 Million Healthy Lives" Initiative for the Early Detection of Genetic Diseases.
Listening time ≈ 3 minutes
Speed

The Ministry of Health and Population announced the screening of 735,884 newborns under the President's initiative for the early detection of genetic diseases, under the slogan "100 Million Healthy Lives", since its launch on 13 July 2021 to date, with the aim of building a healthy generation free of the causes of disability.

Dr. Hossam Abdel Ghaffar, the Ministry's Official Spokesperson, affirmed that the initiative is currently in its first phase, which targets the detection of 19 genetic diseases among premature babies in the incubators of the Ministry's hospitals, while the second phase will include a comprehensive medical survey of all newborns at all health units nationwide.

He explained that the targeted diseases include: congenital hypothyroidism, G6PD deficiency (favism), phenylketonuria, fatty acid oxidation disorders, glutaric acidemia, isovaleric acidemia, congenital adrenal hyperplasia, cystic fibrosis, tetrahydrobiopterin deficiency, maple syrup urine disease, tyrosinemia (type I), galactosemia, homocystinuria, argininemia, citrullinemia, ornithine transcarbamylase deficiency and biotinidase deficiency.

Abdel Ghaffar added that the screening is carried out by taking a simple blood sample from the baby's heel and analysing it in the laboratories of the Egyptian Center for Disease Control and Prevention (Egyptian CDC), which are equipped with the latest global technologies. If the result is positive, the baby is immediately referred for a confirmatory test and to begin free treatment according to the latest scientific protocols.

He pointed out that 56 specialised centres have been allocated for the treatment and follow-up of genetic diseases in newborns, in cooperation with the Supreme Council of University Hospitals, distributed across the governorates of the Republic, providing treatment services, periodic follow-up, and psychological support and counselling for parents free of charge.

The Ministry affirms the continuation of the initiative as a cornerstone of primary healthcare, calling on citizens to contact the hotlines 105 and 15335 for any enquiries, to ensure the health of Egypt's coming generations, free of genetic disabilities that can be detected and treated early.